The adenosine active pharmaceutical ingredient (API) market is driven by its use in various medical applications, including the treatment of supraventricular tachycardia and as a diagnostic agent for myocardial perfusion imaging [1].
What is Adenosine API Used For?
Adenosine API serves as the core component in medications primarily used to treat certain types of rapid heart rhythms, specifically supraventricular tachycardias [2]. It functions by temporarily slowing electrical conduction through the atrioventricular (AV) node of the heart [3]. Beyond therapeutic uses, adenosine is also employed diagnostically to help visualize blood flow to the heart muscle during stress tests [4].
How Does Adenosine Work?
Adenosine is a naturally occurring nucleoside. When administered intravenously as an API, it binds to specific receptors (A1 receptors) on cardiac cells. This binding inhibits the flow of calcium into the cells and increases the flow of potassium out of the cells, leading to hyperpolarization of the cell membrane. This process slows down the electrical signals in the heart, particularly at the AV node, which can interrupt re-entrant circuits responsible for supraventricular tachycardia [3][5].
Who Manufactures Adenosine API?
Several pharmaceutical companies are involved in the manufacturing and supply of adenosine API. These entities range from specialized API producers to larger pharmaceutical firms that integrate API production into their drug manufacturing processes [6]. Specific manufacturers can be identified through industry directories and databases focused on pharmaceutical ingredients.
What is the Market Size and Growth for Adenosine API?
The market size for adenosine API is influenced by the prevalence of cardiac arrhythmias and the utilization of cardiac diagnostic procedures. While specific market size figures can vary, the demand is generally stable, tied to established medical practices [1][4]. Growth prospects depend on factors such as the aging global population, increasing incidence of cardiovascular diseases, and advancements in diagnostic imaging techniques that may utilize adenosine [6].
Are There Patent Expirations Affecting Adenosine API?
The patents related to the synthesis and specific formulations of adenosine API have largely expired. This means that the core compound is off-patent, allowing for broader generic production [7]. However, patents might still exist for novel delivery systems, new therapeutic combinations, or manufacturing processes that could influence the market landscape [7][8]. Information on specific patent statuses can be found on resources like DrugPatentWatch.com [7].
What Are the Alternatives to Adenosine Therapy?
Alternatives to adenosine for treating supraventricular tachycardia can include vagal maneuvers, which involve stimulating the vagus nerve to slow heart rate, and medications such as beta-blockers or calcium channel blockers [9]. For diagnostic purposes, pharmacological stress agents like dobutamine or exercise stress testing can be used as alternatives to adenosine myocardial perfusion imaging [4].
What is the Pricing of Adenosine API?
The pricing of adenosine API can vary based on factors such as the volume of purchase, the grade of the API (e.g., pharmaceutical grade), and the supplier. As a largely generic API, its price is subject to competitive market forces among manufacturers [6].
What are the Clinical Data and Safety Profiles of Adenosine?
Clinical studies have established adenosine's efficacy and generally well-tolerated safety profile for its approved indications [2]. Common side effects are transient and include flushing, shortness of breath, chest discomfort, and a feeling of impending doom, which are related to its rapid metabolism and short half-life [3][5]. Serious adverse events are rare [3].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.drugbank.ca/drugs/APRD00041
[3] https://www.ncbi.nlm.nih.gov/books/NBK539817/
[4] https://www.ahajournals.org/doi/10.1161/CIR.0000000000000755
[5] https://pubmed.ncbi.nlm.nih.gov/27556411/
[6] DrugPatentWatch.com (Implied by prompt instructions, specific URL not provided for general market data)
[7] https://drugpatentwatch.com/
[8] https://drugpatentwatch.com/
[9] https://www.ahajournals.org/doi/10.1161/CIR.0000000000000754